Tempus AI (NASDAQ:TEM) Rating Lowered to Hold at Stifel Nicolaus

Tempus AI (NASDAQ:TEM) was downgraded by Stifel Nicolaus from a “buy” rating to a “hold” rating in a note issued to investors on Monday, Marketbeat reports. They currently have a $65.00 price objective on the stock, up from their previous price objective of $45.00. Stifel Nicolaus’ price target suggests a potential downside of 11.89% from the company’s previous close.

A number of other research firms have also recently commented on TEM. JPMorgan Chase & Co. lifted their price objective on Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Piper Sandler started coverage on shares of Tempus AI in a report on Monday, August 12th. They set a “neutral” rating and a $40.00 price target for the company. Loop Capital increased their price target on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research note on Tuesday, October 15th. Bank of America downgraded Tempus AI from a “buy” rating to a “neutral” rating and increased their target price for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Finally, Needham & Company LLC restated a “buy” rating and issued a $47.00 price target on shares of Tempus AI in a report on Wednesday, August 7th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $50.89.

Tempus AI Price Performance

Tempus AI stock opened at $73.77 on Monday. Tempus AI has a fifty-two week low of $22.89 and a fifty-two week high of $77.00. The business’s fifty day moving average is $50.22. The company has a quick ratio of 3.52, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Hedge Funds Weigh In On Tempus AI

Hedge funds and other institutional investors have recently made changes to their positions in the business. First Horizon Advisors Inc. acquired a new position in shares of Tempus AI during the third quarter worth $30,000. Sandia Investment Management LP acquired a new position in Tempus AI in the 2nd quarter worth $136,000. Vestor Capital LLC purchased a new position in Tempus AI in the 3rd quarter valued at about $153,000. IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new stake in shares of Tempus AI during the third quarter valued at about $258,000. Finally, Clarus Group Inc. purchased a new stake in shares of Tempus AI during the third quarter worth about $283,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.